TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
ACTU

Actuate Therapeutics, Inc.

Healthcare · Biotechnology

0.7316$ -9.4% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Actuate Therapeutics, Inc. (ACTU) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 5.2 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACTU
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 3.0 2.7 1.7 14 9.3 4.5 7.0 18 14 8.9 5.2
– 3.0 2.2 0.5 14 9.2 4.2 6.7 17 14 8.5 4.7
– 3.0 2.1 0.4 14 8.6 3.9 6.5 17 13 8.1 4.4
– 3.0 2.1 0.4 14 8.6 3.9 6.5 17 13 8.1 4.4
– 103 110 116 8.9 9.2 9.6 9.6 6.8 6.1 5.1 4.2
– 6.9 15 20 8.5 8.8 9.2 9.2 6.4 5.7 4.7 3.8
– – 5.0 6.9 – – – – – – – –
– 3.4 4.0 5.9 2.3 1.9 2.6 3.2 1.2 1.5 1.2 1.1
– -100 -108 -114 5.4 0.1 -5.1 -2.7 11 7.9 3.8 1.0
– -105 -113 -120 -126 -132 -139 -145 -150 -155 -160 -165
15 15 15 20 20 20 19 20 21 23 24 24

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?